CIDRAP newsletters options
In its latest weekly update on the pandemic, the World Health Organization (WHO) said today that global COVID-19 cases declined 6% last week compared to the previous week, though the pace of activity increased in the European region, which experienced an 8% rise compared to the week before.
Venatorx Pharmaceuticals announced this week that it has received a contract from the US Department of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority (BARDA) to develop the combination antibiotic cefipime-taniborbactam for treatment of melioidosis.
Vaccination was tied to a 12% lower risk of NICU care, 27% lower rate of stillbirth, and 54% lower odds of maternal COVID-19.
New statistics from Ohio and Florida published by the National Bureau of Economic Research (NBER) show that Republicans have suffered more COVID-related excess deaths than Democrats, adding to the literature that demonstrates the link between political party affiliation, vaccination uptake, and COVID-19 mortality.
A randomized clinical trial and meta-analysis of previous trials found that topical antibiotics were associated with significantly shorter symptom duration in children with acute infective conjunctivitis, researchers reported today in JAMA Network Open.
Older people were more likely to report symptoms and have abnormal chest imaging and lung function.
Over the past 3 days, Uganda's health ministry has reported 8 more Ebola Sudan cases, along with 2 more deaths, with officials also announcing that a doctor is among the fatal cases.
Since the outbreak was first announced on Sep 20, Uganda continues to report a steady stream of new cases, but so far, the illnesses appear to be limited to hot spots in the west central part of the country near Mubende.
An expert points out, however, that the study didn't adust for risk factors like the number of sex partners.
The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are investigating a multistate Listeria outbreak linked to brie and camembert cheeses.
The oral antiviral drug Paxlovid is safe and effective for treating COVID-19 and carries no additional risk of viral rebound beyond other treatments, according to a meta-analysis published late last week in the Journal of Infection.
Studies detail viral prevalence in various specimens and tattoo- and healthcare-related spread.
In the past, increasing cases in Europe have come ahead of similar rises in other regions.
Inundated US hospitals held patients in places like hallways for a median of 6.6 hours.
A multicenter US study identified widespread nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae (CRKP) within and between healthcare settings, researchers reported yesterday in Clinical Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Uganda's health ministry on Twitter today reported four more lab-confirmed Ebola Sudan cases, as well as one more death in a patient with a confirmed infection. The developments push the country's overall total to 54 cases, 35 of them confirmed and 19 listed as probable. The latest death brings Uganda's fatality count to 25, 7 in confirmed patients and 18 in people who had probable infections.
Retrospective UK testing reveals a case on Mar 7, two months earlier than previously reported.
Officials add 14 more cases to the total, and the fatality count rises to 24.
The shots offered 74% protection against hospitalization or death and 90% against death alone.
A report yesterday from the United Kingdom's Health Security Agency (HSA) shows sexually transmitted Shigella infections are rising again in England after falling during the COVID-19 pandemic.
